The anti-tumor effect of human monocyte-derived dendritic cells loaded with HSV-TK/GCV induced dying cells
/in Hepatocellular Carcinoma, International Publications /von 2008-10-02 / Cell. Immunol. 2009;254(2):135-41In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
/in Hepatocellular Carcinoma, International Publications /von 2008-09-15 / J Transl Med 2008 Sep;6:51CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo
/in Hepatocellular Carcinoma, International Publications /von 2008-07-01 / Hepatology 2008 Jul;48(1):157-68Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line
/in Hepatocellular Carcinoma, International Publications /von 2008-01-01 / Hepatogastroenterology 2008 Jan-Feb;55(81):155-9Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
/in Hepatocellular Carcinoma, International Publications /von 2007-05-24 / Cancer Immunol. Immunother. 2007 Dec;56(12):1931-43AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients
/in Hepatocellular Carcinoma, International Publications /von 2007-05-01 / J. Immunother. 2007 May-Jun;30(4):425-37alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro
/in Hepatocellular Carcinoma, International Publications /von 2007-02-21 / Hum. Immunol. 2007 May;68(5):334-41Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells
/in Hepatocellular Carcinoma, International Publications /von 2006-06-30 / Cell. Immunol. 2006 Feb;239(2):144-50Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2006-06-01 / Cell. Mol. Immunol. 2006 Jun;3(3):197-203
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
- Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
- Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy